82 related articles for article (PubMed ID: 28976503)
1. Nucleobase-modified polyamidoamine-mediated miR-23b delivery to inhibit the proliferation and migration of lung cancer.
Han H; Yang J; Wang Y; Chen W; Chen J; Yang Y; Li Q
Biomater Sci; 2017 Oct; 5(11):2268-2275. PubMed ID: 28976503
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery.
Han H; Chen W; Yang J; Liang X; Wang Y; Li Q; Yang Y; Li K
Int J Nanomedicine; 2018; 13():1297-1311. PubMed ID: 29563788
[TBL] [Abstract][Full Text] [Related]
3. Chondroitin sulfate-functionalized polyamidoamine as a tumor-targeted carrier for miR-34a delivery.
Chen W; Liu Y; Liang X; Huang Y; Li Q
Acta Biomater; 2017 Jul; 57():238-250. PubMed ID: 28511876
[TBL] [Abstract][Full Text] [Related]
4. N-Isopropylacrylamide-modified polyethylenimine-mediated miR-29a delivery to inhibit the proliferation and migration of lung cancer cells.
Xing J; Jia J; Cong X; Liu Z; Li Q
Colloids Surf B Biointerfaces; 2021 Feb; 198():111463. PubMed ID: 33250420
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
[TBL] [Abstract][Full Text] [Related]
6. The expressions of miR-151a-5p and miR-23b in lung cancer tissues and their effects on the biological functions of lung cancer A549 cells.
Guo S; Zhang J; Zhao YY; Zhou LY; Xie Y; Wu XY; Bian X; Yu XY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6779-6785. PubMed ID: 32633369
[TBL] [Abstract][Full Text] [Related]
7. Fluoropolymer-Mediated Intracellular Delivery of miR-23b for the Osteocyte Differentiation in Osteoblasts.
Wang S; Xing J; Xiong B; Han H; Hu M; Li Q
Macromol Biosci; 2021 May; 21(5):e2100024. PubMed ID: 33713529
[TBL] [Abstract][Full Text] [Related]
8. Phenylboronic acid-functionalized polyamidoamine-mediated miR-34a delivery for the treatment of gastric cancer.
Song Z; Liang X; Wang Y; Han H; Yang J; Fang X; Li Q
Biomater Sci; 2019 Mar; 7(4):1632-1642. PubMed ID: 30720809
[TBL] [Abstract][Full Text] [Related]
9. Phenylboronic acid-modified polyamidoamine-mediated delivery of short GC rich DNA for hepatocarcinoma gene therapy.
Yang J; Zhang J; Liu Y; Shi Z; Han H; Li Q
Biomater Sci; 2019 Aug; 7(8):3348-3358. PubMed ID: 31218303
[TBL] [Abstract][Full Text] [Related]
10. [Downregulation of miR-18a or miR-328 inhibits the invasion and migration of lung adenocarcinoma A549 cells].
DU C; Zheng J; Lu X; Wang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1051-4. PubMed ID: 27412935
[TBL] [Abstract][Full Text] [Related]
11. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-101 regulates the viability and invasion of cervical cancer cells.
Lin C; Huang F; Shen G; Yiming A
Int J Clin Exp Pathol; 2015; 8(9):10148-55. PubMed ID: 26617722
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells.
Zhang S; Ma C; Pang H; Zeng F; Cheng L; Fang B; Ma J; Shi Y; Hong H; Chen J; Wang Z; Xia J
Biochem Biophys Res Commun; 2016 Jan; 469(1):55-61. PubMed ID: 26592661
[TBL] [Abstract][Full Text] [Related]
15. An ATP-Responsive Codelivery System of Doxorubicin and MiR-34a To Synergistically Inhibit Cell Proliferation and Migration.
Wang Y; Chen J; Liang X; Han H; Wang H; Yang Y; Li Q
Mol Pharm; 2017 Jul; 14(7):2323-2332. PubMed ID: 28591517
[TBL] [Abstract][Full Text] [Related]
16. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
18. The novel miR-9501 inhibits cell proliferation, migration and activates apoptosis in non-small cell lung cancer.
Xi Y; Wang L; Sun C; Yang C; Zhang F; Li D
Med Oncol; 2016 Nov; 33(11):124. PubMed ID: 27734264
[TBL] [Abstract][Full Text] [Related]
19. miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells.
Chen X; Wang Y; Zang W; Du Y; Li M; Zhao G
Tumour Biol; 2015 Apr; 36(4):2393-401. PubMed ID: 25412959
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2.
Kong XM; Zhang GH; Huo YK; Zhao XH; Cao DW; Guo SF; Li AM; Zhang XR
Int J Clin Exp Pathol; 2015; 8(10):12845-52. PubMed ID: 26722475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]